Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026)
Lemaitre Vascular (LMAT) reported Non-Current Assets of $151.7 million for Q1 2026, up 2.58% year-over-year from $147.9 million in Q1 2025, and up 254.79% quarter-over-quarter from $42.8 million in Q4 2025.
Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Non-Current Assets data on file, last reported at $151.7 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $151.7 million, up 2.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $593.1 million (down 0.99% YoY), and the FY2025 annual result was $42.8 million, up 2.87% from the prior year.
- Non-Current Assets improved to $151.7 million in Q1 2026 per LMAT's latest filing, from $42.8 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $152.0 million in Q2 2023 and troughed at $33.5 million in Q4 2022.
- A 5-year average of $123.9 million and a median of $149.9 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets declined 4.21% in 2022, then grew 18.63% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $33.5 million in 2022, then grew by 18.63% to $39.8 million in 2023, then rose by 4.49% to $41.6 million in 2024, then rose by 2.87% to $42.8 million in 2025, then jumped by 254.79% to $151.7 million in 2026.
- Business Quant data shows LMAT's Non-Current Assets at $151.7 million in Q1 2026, $42.8 million in Q4 2025, and $146.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 11.30 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 42.82 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 27.83 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 4.72 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 2.28 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 10.51 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.66 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.00 Bn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | 151.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.71 Mn |
| Dec 31, 2025 | 42.76 Mn |
| Sep 30, 2025 | 146.04 Mn |
| Jun 30, 2025 | 147.47 Mn |
| Mar 31, 2025 | 147.89 Mn |
| Dec 31, 2024 | 41.57 Mn |
| Sep 30, 2024 | 149.91 Mn |
| Jun 30, 2024 | 150.27 Mn |
| Mar 31, 2024 | 151.00 Mn |
| Dec 31, 2023 | 39.78 Mn |
| Sep 30, 2023 | 151.83 Mn |
| Jun 30, 2023 | 151.98 Mn |
| Mar 31, 2023 | 150.10 Mn |
| Dec 31, 2022 | 33.54 Mn |
| Sep 30, 2022 | 148.91 Mn |
| Jun 30, 2022 | 150.94 Mn |
| Mar 31, 2022 | 151.04 Mn |
| Dec 31, 2021 | 32.13 Mn |
| Sep 30, 2021 | 155.46 Mn |
| Jun 30, 2021 | 156.49 Mn |